Guardant Health posts strong Q3 revenue growth but raises full‑year cash‑burn outlook
Guardant Health reported third‑quarter 2026 revenue of $360.98 million, up 36.1% year over year, while its net loss widened to $124.36 million. The company lifted its full‑year revenue guidance to $1.36 billion‑$1.37 billion and increased its free‑cash‑flow burn outlook to $205 million‑$220 million. Despite the earnings beat, the stock slipped about 5.5% in after‑hours trading.
Why it matters
The higher cash‑burn forecast signals greater spending to scale commercial operations, which may pressure cash runway and affect investor sentiment, as reflected by the share‑price decline (the company notes the market reaction to the burn guidance).
Key facts
- 1Q3 2026 revenue was $360.98 million, a 36.1% increase versus the prior year quarter. tradingview.com
- 2Net loss for the quarter was $124.36 million. tradingview.com
- 3Adjusted earnings per share were -$0.29. finance.yahoo.com
- 4Full‑year 2026 revenue guidance was raised to $1.36 billion‑$1.37 billion. investing.com
- 5Full‑year free cash flow burn guidance was increased to $205 million‑$220 million. investing.com
- 6Shares fell approximately 5.5% in pre‑market trading after the release. investing.com
Summary written by AlphAI AI Desk from 10 of 10 sources. Not investment advice. Figures are as stated by the linked sources.